Chapter 8 Pain
問題一覧
1
"How would you describe your pain?"
2
Breakthrough pain
3
"The drug decreases production of pain-sensitizing chemicals."
4
"I can accomplish activities without much discomfort."
5
"The strategies work by affecting the perception of pain."
6
Offer immediate-release morphine 30 mg orally.
7
"Does the pain keep you from activities that you enjoy?"
8
Consult with the health care provider about using a different treatment protocol to control the patient's pain.
9
Ask if the patient feels the need to void.
10
Titrate the prescribed morphine dose up until the patient indicates adequate pain relief.
11
Meperidine (Demerol) 25 mg every 4 hours*
12
Hydromorphone (Dilaudid) IV
13
Amitriptyline
14
Wake the patient and administer the hydrocodone.
15
Pentazocine (Talwin)
16
Checking the respiratory rate
17
The patient will be able to play a round of golf.
18
Administer the ordered antiemetic medication.
19
Administer the prescribed PRN immediate-acting morphine.
20
Count the respiratory rate every 2 hours.
21
Remove the fentanyl patch.
22
Acetaminophen 650 mg orally
23
Patient who was treated for pain just prior to return from the postanesthesia care unit
24
Monitor for therapeutic and adverse effects of opioid administration., Teach the patient about how analgesics improve postoperative activity levels.
25
Confusion, Poor cough effort, Shallow breathing, Elevated temperature
26
MS Contin 30 mg/dose
27
Sharp, Prickly, Burning, Stabbing, Electric shock-like
28
Nonpharmacologic pain relief therapies, Side effects and complications associated with medications, Adjustments in drug dosages that may be required over a period of time
29
Monitor respiratory status, Monitor sedation level, Consider administering naloxone
30
Rhinorrhea, Diaphoresis, Lacrimation
31
Decreasing opioid dose 25% to 50%, Administering opioid-sparing nonopioid to the patient, Monitoring the patient's respiratory status continuously
32
Administer a higher dosage of the fentanyl.
33
Administer oxygen to the patient., Make attempts to arouse the patient., Obtain a prescription to reduce the dosage of opioid medications.
34
1 minute
35
Help the patient establish a number system to rate his or her fatigue goal.
36
Difficulty breathing, Excessive sleepiness
37
If prescribed, decrease the opioid dose 25% to 50%
38
Intense burning pain, Increased skin sensitivity, Swelling of the affected limb
39
Intravenous
40
Teach the caregiver not to push the button for the patient.
41
Pain needs to be reported if it is not relieved to tolerable levels
42
0803
43
Duloxetine, Venlafaxine, Amitriptyline
44
Ibuprofen, Acetaminophen
45
"I usually get a pain in the jaws.", "Moving my neck is very painful.", "The pain seems to radiate through my left arm."
46
Increasing the dose of the drug will not provide greater analgesia., Increasing the dose will produce deleterious effects on body systems.
47
Consider administering a nonsedating opioid-sparing nonopioid, such as acetaminophen or ibuprofen., Monitor respiratory status and sedation level closely until sedation level is stable (less than 3) and respiratory status is satisfactory., Decrease the opioid dose by 25%-50% or contact the primary care provider for orders to determine dose reduction for the opioid.
48
Educate patients and their families about pain management, Educate health care providers about pain assessment and management of pain, Recognize the patient's right to appropriate assessment and management of pain
49
Celecoxib
50
A patient with decreased cognitive function
51
Contributes to unnecessary suffering and physical and psychosocial dysfunction
52
Physiologic, Affective, Cognitive, Behavioral, Sociocultural
53
The transmission may be interrupted by drugs such as local anesthetics.
54
Palpation of the liver
55
The area should be treated as a painful lesion, using gentle cleansing and dressing.
56
1.Transduction, 2.Transmission, 3.Perception, 4.Modulation
57
Treatment includes the use of adjuvant analgesics
58
On an around-the-clock schedule
59
Add PO oxycodone (Oxycontin) to the other medications
60
Adverse respiratory outcomes
61
Unrelieved pain has many harmful effects on the body that can impair recovery.
62
Duragesic
study
study
ユーザ名非公開 · 61問 · 1年前study
study
61問 • 1年前39
39
ユーザ名非公開 · 28問 · 1年前39
39
28問 • 1年前pretest
pretest
ユーザ名非公開 · 10問 · 1年前pretest
pretest
10問 • 1年前Chapter 1. History of Pharmacology
Chapter 1. History of Pharmacology
ユーザ名非公開 · 10問 · 1年前Chapter 1. History of Pharmacology
Chapter 1. History of Pharmacology
10問 • 1年前Chapter 2. Basics of Pharmacology
Chapter 2. Basics of Pharmacology
ユーザ名非公開 · 15問 · 1年前Chapter 2. Basics of Pharmacology
Chapter 2. Basics of Pharmacology
15問 • 1年前Chapter 3
Chapter 3
ユーザ名非公開 · 11問 · 1年前Chapter 3
Chapter 3
11問 • 1年前Chapter 4
Chapter 4
ユーザ名非公開 · 10問 · 1年前Chapter 4
Chapter 4
10問 • 1年前Chapter 5
Chapter 5
ユーザ名非公開 · 10問 · 1年前Chapter 5
Chapter 5
10問 • 1年前Chapter 9
Chapter 9
ユーザ名非公開 · 13問 · 1年前Chapter 9
Chapter 9
13問 • 1年前Chapter 10
Chapter 10
ユーザ名非公開 · 9問 · 1年前Chapter 10
Chapter 10
9問 • 1年前Chapter 11
Chapter 11
ユーザ名非公開 · 72問 · 1年前Chapter 11
Chapter 11
72問 • 1年前Chapter 12
Chapter 12
ユーザ名非公開 · 32問 · 1年前Chapter 12
Chapter 12
32問 • 1年前Chapter 15
Chapter 15
ユーザ名非公開 · 32問 · 1年前Chapter 15
Chapter 15
32問 • 1年前Chapter 13
Chapter 13
ユーザ名非公開 · 25問 · 1年前Chapter 13
Chapter 13
25問 • 1年前FULL CHAPTER 61
FULL CHAPTER 61
ユーザ名非公開 · 100問 · 1年前FULL CHAPTER 61
FULL CHAPTER 61
100問 • 1年前Chapter 62
Chapter 62
ユーザ名非公開 · 45問 · 1年前Chapter 62
Chapter 62
45問 • 1年前Immune System Disorder
Immune System Disorder
ユーザ名非公開 · 10問 · 1年前Immune System Disorder
Immune System Disorder
10問 • 1年前Endocrine VID
Endocrine VID
ユーザ名非公開 · 43問 · 1年前Endocrine VID
Endocrine VID
43問 • 1年前Chapter 49
Chapter 49
ユーザ名非公開 · 58問 · 1年前Chapter 49
Chapter 49
58問 • 1年前Chapter 49 PT2
Chapter 49 PT2
ユーザ名非公開 · 54問 · 1年前Chapter 49 PT2
Chapter 49 PT2
54問 • 1年前22
22
ユーザ名非公開 · 22問 · 1年前22
22
22問 • 1年前Chapter 50
Chapter 50
ユーザ名非公開 · 43問 · 1年前Chapter 50
Chapter 50
43問 • 1年前Chapter 50 PT 2
Chapter 50 PT 2
ユーザ名非公開 · 50問 · 1年前Chapter 50 PT 2
Chapter 50 PT 2
50問 • 1年前Chapter 50 PT 3
Chapter 50 PT 3
ユーザ名非公開 · 41問 · 1年前Chapter 50 PT 3
Chapter 50 PT 3
41問 • 1年前Chapter 50 PT 4
Chapter 50 PT 4
ユーザ名非公開 · 29問 · 1年前Chapter 50 PT 4
Chapter 50 PT 4
29問 • 1年前Chapter 34: Hypertension
Chapter 34: Hypertension
ユーザ名非公開 · 45問 · 1年前Chapter 34: Hypertension
Chapter 34: Hypertension
45問 • 1年前Chapter 34: Hypertension PT2
Chapter 34: Hypertension PT2
ユーザ名非公開 · 50問 · 1年前Chapter 34: Hypertension PT2
Chapter 34: Hypertension PT2
50問 • 1年前Chapter 34: Hypertension PT3
Chapter 34: Hypertension PT3
ユーザ名非公開 · 38問 · 1年前Chapter 34: Hypertension PT3
Chapter 34: Hypertension PT3
38問 • 1年前Chapter 34: Hypertension PT4
Chapter 34: Hypertension PT4
ユーザ名非公開 · 45問 · 1年前Chapter 34: Hypertension PT4
Chapter 34: Hypertension PT4
45問 • 1年前Chapter 34: Hypertension PT5
Chapter 34: Hypertension PT5
ユーザ名非公開 · 50問 · 1年前Chapter 34: Hypertension PT5
Chapter 34: Hypertension PT5
50問 • 1年前Chapter 33
Chapter 33
ユーザ名非公開 · 49問 · 1年前Chapter 33
Chapter 33
49問 • 1年前Chapter 35: Cardiac Disorders
Chapter 35: Cardiac Disorders
ユーザ名非公開 · 10問 · 1年前Chapter 35: Cardiac Disorders
Chapter 35: Cardiac Disorders
10問 • 1年前Chapter 33: Cardiovascular System Introduction Chapter 35: Cardiac Disorders
Chapter 33: Cardiovascular System Introduction Chapter 35: Cardiac Disorders
ユーザ名非公開 · 50問 · 1年前Chapter 33: Cardiovascular System Introduction Chapter 35: Cardiac Disorders
Chapter 33: Cardiovascular System Introduction Chapter 35: Cardiac Disorders
50問 • 1年前PT 2
PT 2
ユーザ名非公開 · 50問 · 1年前PT 2
PT 2
50問 • 1年前PT 3
PT 3
ユーザ名非公開 · 55問 · 1年前PT 3
PT 3
55問 • 1年前PT 4
PT 4
ユーザ名非公開 · 53問 · 1年前PT 4
PT 4
53問 • 1年前PT 5
PT 5
ユーザ名非公開 · 49問 · 1年前PT 5
PT 5
49問 • 1年前Chapter 36
Chapter 36
ユーザ名非公開 · 14問 · 1年前Chapter 36
Chapter 36
14問 • 1年前Vascular Disorders
Vascular Disorders
ユーザ名非公開 · 55問 · 1年前Vascular Disorders
Vascular Disorders
55問 • 1年前PT 2
PT 2
ユーザ名非公開 · 55問 · 1年前PT 2
PT 2
55問 • 1年前PT 3
PT 3
ユーザ名非公開 · 39問 · 1年前PT 3
PT 3
39問 • 1年前Chapter 43 Musculoskeletal System Introduction
Chapter 43 Musculoskeletal System Introduction
ユーザ名非公開 · 10問 · 1年前Chapter 43 Musculoskeletal System Introduction
Chapter 43 Musculoskeletal System Introduction
10問 • 1年前Chapter 44: Connective Tissue Disorders
Chapter 44: Connective Tissue Disorders
ユーザ名非公開 · 26問 · 1年前Chapter 44: Connective Tissue Disorders
Chapter 44: Connective Tissue Disorders
26問 • 1年前PT 2
PT 2
ユーザ名非公開 · 49問 · 1年前PT 2
PT 2
49問 • 1年前PT 3
PT 3
ユーザ名非公開 · 49問 · 1年前PT 3
PT 3
49問 • 1年前PT 4
PT 4
ユーザ名非公開 · 55問 · 1年前PT 4
PT 4
55問 • 1年前PT 5
PT 5
ユーザ名非公開 · 36問 · 1年前PT 5
PT 5
36問 • 1年前Chapter 45: Fractures
Chapter 45: Fractures
ユーザ名非公開 · 29問 · 1年前Chapter 45: Fractures
Chapter 45: Fractures
29問 • 1年前Chapter 46: Amputations
Chapter 46: Amputations
ユーザ名非公開 · 31問 · 1年前Chapter 46: Amputations
Chapter 46: Amputations
31問 • 1年前Chapter 45: Fractures Chapter 46: Amputations
Chapter 45: Fractures Chapter 46: Amputations
ユーザ名非公開 · 40問 · 1年前Chapter 45: Fractures Chapter 46: Amputations
Chapter 45: Fractures Chapter 46: Amputations
40問 • 1年前PT 2
PT 2
ユーザ名非公開 · 45問 · 1年前PT 2
PT 2
45問 • 1年前PT 3
PT 3
ユーザ名非公開 · 40問 · 1年前PT 3
PT 3
40問 • 1年前PT 4
PT 4
ユーザ名非公開 · 45問 · 1年前PT 4
PT 4
45問 • 1年前Chapter 56
Chapter 56
ユーザ名非公開 · 27問 · 1年前Chapter 56
Chapter 56
27問 • 1年前Chapter 57: Skin Disorders
Chapter 57: Skin Disorders
ユーザ名非公開 · 18問 · 1年前Chapter 57: Skin Disorders
Chapter 57: Skin Disorders
18問 • 1年前Chapter 56: New Integumentary System Introduction Chapter 57: Skin Disorders
Chapter 56: New Integumentary System Introduction Chapter 57: Skin Disorders
ユーザ名非公開 · 40問 · 1年前Chapter 56: New Integumentary System Introduction Chapter 57: Skin Disorders
Chapter 56: New Integumentary System Introduction Chapter 57: Skin Disorders
40問 • 1年前PT 2
PT 2
ユーザ名非公開 · 50問 · 1年前PT 2
PT 2
50問 • 1年前PT 3
PT 3
ユーザ名非公開 · 50問 · 1年前PT 3
PT 3
50問 • 1年前PT 4
PT 4
ユーザ名非公開 · 50問 · 1年前PT 4
PT 4
50問 • 1年前Chapter 25: Respiratory System Introduction
Chapter 25: Respiratory System Introduction
ユーザ名非公開 · 37問 · 1年前Chapter 25: Respiratory System Introduction
Chapter 25: Respiratory System Introduction
37問 • 1年前Chapter 26: Upper Respiratory Disorders
Chapter 26: Upper Respiratory Disorders
ユーザ名非公開 · 14問 · 1年前Chapter 26: Upper Respiratory Disorders
Chapter 26: Upper Respiratory Disorders
14問 • 1年前Chapter 27: Acute Lower Respiratory Disorders
Chapter 27: Acute Lower Respiratory Disorders
ユーザ名非公開 · 17問 · 1年前Chapter 27: Acute Lower Respiratory Disorders
Chapter 27: Acute Lower Respiratory Disorders
17問 • 1年前Chapter 27: Acute Lower Respiratory Disorders 1
Chapter 27: Acute Lower Respiratory Disorders 1
ユーザ名非公開 · 50問 · 1年前Chapter 27: Acute Lower Respiratory Disorders 1
Chapter 27: Acute Lower Respiratory Disorders 1
50問 • 1年前PT 2
PT 2
ユーザ名非公開 · 45問 · 1年前PT 2
PT 2
45問 • 1年前PT 3
PT 3
ユーザ名非公開 · 45問 · 1年前PT 3
PT 3
45問 • 1年前PT 4
PT 4
ユーザ名非公開 · 45問 · 1年前PT 4
PT 4
45問 • 1年前PT 5
PT 5
ユーザ名非公開 · 50問 · 1年前PT 5
PT 5
50問 • 1年前PT 6
PT 6
ユーザ名非公開 · 18問 · 1年前PT 6
PT 6
18問 • 1年前Chapter 07
Chapter 07
ユーザ名非公開 · 8問 · 12ヶ月前Chapter 07
Chapter 07
8問 • 12ヶ月前問題一覧
1
"How would you describe your pain?"
2
Breakthrough pain
3
"The drug decreases production of pain-sensitizing chemicals."
4
"I can accomplish activities without much discomfort."
5
"The strategies work by affecting the perception of pain."
6
Offer immediate-release morphine 30 mg orally.
7
"Does the pain keep you from activities that you enjoy?"
8
Consult with the health care provider about using a different treatment protocol to control the patient's pain.
9
Ask if the patient feels the need to void.
10
Titrate the prescribed morphine dose up until the patient indicates adequate pain relief.
11
Meperidine (Demerol) 25 mg every 4 hours*
12
Hydromorphone (Dilaudid) IV
13
Amitriptyline
14
Wake the patient and administer the hydrocodone.
15
Pentazocine (Talwin)
16
Checking the respiratory rate
17
The patient will be able to play a round of golf.
18
Administer the ordered antiemetic medication.
19
Administer the prescribed PRN immediate-acting morphine.
20
Count the respiratory rate every 2 hours.
21
Remove the fentanyl patch.
22
Acetaminophen 650 mg orally
23
Patient who was treated for pain just prior to return from the postanesthesia care unit
24
Monitor for therapeutic and adverse effects of opioid administration., Teach the patient about how analgesics improve postoperative activity levels.
25
Confusion, Poor cough effort, Shallow breathing, Elevated temperature
26
MS Contin 30 mg/dose
27
Sharp, Prickly, Burning, Stabbing, Electric shock-like
28
Nonpharmacologic pain relief therapies, Side effects and complications associated with medications, Adjustments in drug dosages that may be required over a period of time
29
Monitor respiratory status, Monitor sedation level, Consider administering naloxone
30
Rhinorrhea, Diaphoresis, Lacrimation
31
Decreasing opioid dose 25% to 50%, Administering opioid-sparing nonopioid to the patient, Monitoring the patient's respiratory status continuously
32
Administer a higher dosage of the fentanyl.
33
Administer oxygen to the patient., Make attempts to arouse the patient., Obtain a prescription to reduce the dosage of opioid medications.
34
1 minute
35
Help the patient establish a number system to rate his or her fatigue goal.
36
Difficulty breathing, Excessive sleepiness
37
If prescribed, decrease the opioid dose 25% to 50%
38
Intense burning pain, Increased skin sensitivity, Swelling of the affected limb
39
Intravenous
40
Teach the caregiver not to push the button for the patient.
41
Pain needs to be reported if it is not relieved to tolerable levels
42
0803
43
Duloxetine, Venlafaxine, Amitriptyline
44
Ibuprofen, Acetaminophen
45
"I usually get a pain in the jaws.", "Moving my neck is very painful.", "The pain seems to radiate through my left arm."
46
Increasing the dose of the drug will not provide greater analgesia., Increasing the dose will produce deleterious effects on body systems.
47
Consider administering a nonsedating opioid-sparing nonopioid, such as acetaminophen or ibuprofen., Monitor respiratory status and sedation level closely until sedation level is stable (less than 3) and respiratory status is satisfactory., Decrease the opioid dose by 25%-50% or contact the primary care provider for orders to determine dose reduction for the opioid.
48
Educate patients and their families about pain management, Educate health care providers about pain assessment and management of pain, Recognize the patient's right to appropriate assessment and management of pain
49
Celecoxib
50
A patient with decreased cognitive function
51
Contributes to unnecessary suffering and physical and psychosocial dysfunction
52
Physiologic, Affective, Cognitive, Behavioral, Sociocultural
53
The transmission may be interrupted by drugs such as local anesthetics.
54
Palpation of the liver
55
The area should be treated as a painful lesion, using gentle cleansing and dressing.
56
1.Transduction, 2.Transmission, 3.Perception, 4.Modulation
57
Treatment includes the use of adjuvant analgesics
58
On an around-the-clock schedule
59
Add PO oxycodone (Oxycontin) to the other medications
60
Adverse respiratory outcomes
61
Unrelieved pain has many harmful effects on the body that can impair recovery.
62
Duragesic